Novo Nordisk A/S - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US6701002056

SecurityNVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionAsset Dedication, LLC
Latest Disclosed Ownership1,605 shares
Latest Disclosed Value $ 58,984
Asset Dedication, LLC reports 8.55% decrease in ownership of NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 29, 2026 - Asset Dedication, LLC filed a 13F-HR form disclosing ownership of 1,605 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (US:NVO) valued at $58,984 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 1,755 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -8.55% during the quarter. The current value of the position is $70,219 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 1,605 -150 -8.55 59 -34.83 0.0041
2026-01-26 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 1,755 -610 -25.79 89 -32.06 0.0059
2025-11-20 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 2,365 0 0.00 131 -19.63 0.0088
2025-08-19 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 2,365 -12 -0.50 163 -1.21 0.0119
2025-05-01 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 2,377 12 0.51 165 -18.72 0.0134
2025-01-23 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 2,365 11 0.47 203 -27.50 0.0160
2024-10-15 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 2,354 440 22.99 280 2.56 0.0189
2024-08-06 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 1,914 0 0.00 273 0.0189
2024-04-16 2024-03-31 13F Novo Nordisk A Equities 670100205 1,914 0 0.00 0 0.0184
2024-02-08 2023-12-31 13F Novo Nordisk A Equities 670100205 1,914 0 0.00 0 0.0161
2023-11-13 2023-09-30 13F Novo Nordisk A Equities 670100205 1,914 557 41.05 0 0.0148
2023-08-22 2023-06-30 13F Novo Nordisk A Equities 670100205 1,357 400 41.80 0 0.0187
2023-04-24 2023-03-31 13F Novo Nordisk A Equities 670100205 957 0 0.00 0 0.0140
2023-01-19 2022-12-31 13F Novo Nordisk A Equities 670100205 957 0 0.00 0 -100.00 0.0131
2022-10-27 2022-09-30 13F Novo Nordisk A Equities 670100205 957 957 96 0.0105
2022-07-18 2022-06-30 13F Novo Nordisk A Equities 670100205 0 -957 -100.00 0 -100.00
2022-04-21 2022-03-31 13F Novo Nordisk A Equities 670100205 957 0 0.00 106 -0.93 0.0118
2022-01-21 2021-12-31 13F Novo Nordisk A Equities 670100205 957 0 0.00 107 17.58 0.0129
2021-10-18 2021-09-30 13F Novo Nordisk A Equities 670100205 957 160 20.08 91 35.82 0.0120
2021-07-21 2021-06-30 13F Novo Nordisk A Equities 670100205 797 38 5.01 67 31.37 0.0100
2021-05-03 2021-03-31 13F Novo Nordisk A Equities 670100205 759 721 1,897.37 51 1,600.00 0.0115
2021-01-28 2020-12-31 13F Novo Nordisk A Equities 670100205 38 0 0.00 3 0.00 0.0006
2020-10-20 2020-09-30 13F Novo Nordisk A Equities 670100205 38 38 3 0.0007
2018-10-26 2018-09-30 13F Novo Nordisk A Equities 670100205 0 -1 -100.00 0 0.0000
2018-08-13 2018-06-30 13F Novo Nordisk A Equities 670100205 1 1 0 0.0000
2017-04-20 2017-03-31 13F Novo Nordisk A Equities 670100205 0 -297 -100.00 0 -100.00
2017-01-17 2016-12-31 13F Novo Nordisk A Equities 670100205 297 -288 -49.23 11 -54.17 0.0064
2016-11-18 2016-09-30 13F/A-2 Novo Nordisk A Equities 670100205 585 -707 -54.72 24 -65.22 0.0152
2016-10-19 2016-09-30 13F Novo-Nordisk A-S Adr Equities 670100205 1,292 70
2016-11-18 2016-06-30 13F/A-1 Novo Nordisk A Equities 670100205 1,292 0 0.00 69 -1.43 0.0479
2016-07-14 2016-06-30 13F Novo-Nordisk A-S Adr Equities 670100205 1,292 70
2016-04-27 2016-03-31 13F Novo-Nordisk A-S Adr Equities 670100205 1,292 -690 -34.81 70 -39.13 0.0515
2016-02-16 2015-12-31 13F Novo-Nordisk A-S Adr EQUITIES 670100205 1,982 1,982 115 0.0755
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.